| Literature DB >> 29510760 |
Lucie Jedličková1, Hana Dvořáková2, Jan Dvořák3,4, Martin Kašný2,5, Lenka Ulrychová2,6, Jiří Vorel5, Vojtěch Žárský7, Libor Mikeš2.
Abstract
BACKGROUND:Entities:
Keywords: Blood digestion; Cathepsin; Cysteine peptidase; Diplozoidae; Eudiplozoon nipponicum; Fish parasite; Haematophagy; Monogenea; Protease; S2 subsite
Mesh:
Substances:
Year: 2018 PMID: 29510760 PMCID: PMC5840727 DOI: 10.1186/s13071-018-2666-2
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Predicted/computed sequence-derived features of E. nipponicum cathepsins L and B
| Transcript_ID | Bases/AA | Completeness | SP | pI proenzyme/mature enzyme | MW proenzyme/mature enzyme (kDa) | N-/O-glyc sites | |
|---|---|---|---|---|---|---|---|
| CL1 | E_nip_trans_58808_m.372114 | 954/317 | yes | no | 5.86/6.08 | 34.9/24.36 | 0/7 |
| CL2 | E_nip_trans_70234_m.461805 | 1029/342 | yes | yes | 7.23/4.87 | 37/24.9 | 3/2 |
| CL3 | E_nip_trans_02967_m.11341 | 1107/368 | yes | yes | 4.80/4.15 | 38/24.1 | 0/5 |
| CL4 | E_nip_trans_06099_m.25531 | 1062/353 | yes | yes | 5.59/4.94 | 37.6/24.2 | 3/8 |
| CL5 | E_nip_trans_65378_m.396731 | 1071/356 | yes | no | 5.62/5.02 | 39.5/24 | 1/8 |
| CL6a | E_nip_trans_15113_m.115989 | 1059/352 | yes | yes | 5.55/4.8 | 37.7/24.4 | 0/2 |
| CL6b | E_nip_trans_04751_m.20488 | 519/173 | iN | ? | ?/? | ?/? | 0/0 |
| CL6c | E_nip_trans_04670_m.20209 | 642/214 | iC | yes | ?/? | ?/? | 0/4 |
| CL6d | E_nip_trans_55822_m.362291 | 705/235 | iC | yes | ?/? | ?/? | 0/1 |
| CL6e | E_nip_trans_60687_m.380367 | 768/255 | iN | ? | ?/4.58 | ?/24.47 | 0/2 |
| CB | E_nip_trans_02724_m.9562 | 1149/382 | yes | yes | 7.21/5.55 | 39.9/28.5 | 1/7 |
Abbreviations: AA Amino acids, SP Signal peptide, N-/O-glyc sites Number of potential N-glycosylation/O-glycosylation sites, iN Incomplete N-terminus, iC Incomplete C-terminus, ? data not available due to an incomplete sequence
Fig. 1Relative transcription rate of E. nipponicum cathepsins L. The relative transcription rate predicted by a back mapping of raw Illumina reads to the assembled transcripts was calculated as the percentage of all cathepsin L transcripts
Fig. 2Collapsed phylogram showing relationships between E. nipponicum cathepsins L and cathepsins L of other selected organisms. Collapsed unrooted maximum-likelihood tree of selected E. nipponicum cathepsins L inferred using the best-fit model (LG + C60 + G). Leaves of related organisms are collapsed. Ultrafast bootstrap supports and posterior probabilities are shown where ultrafast bootstrap is ≥ 50 or posterior probability ≥ 0.9. Maximum support (100/1.0) is indicated by a black circle
Fig. 3SDS-PAGE and affinity−/immunoblots of yrEnCL1, yrEnCL3 and yrEnCB after purification. a 12% gel stained with Coomassie Brilliant Blue. b affinity blot labelling by iBody4. c immunoblot detection by anti-His-Tag antibody. Lane 1: yrEnCL1 (28 kDa partially processed form); Lane 2: yrEnCL3 (38 kDa pro-enzyme); Lane 3: yrEnCB (29 kDa deglycosylated processed enzyme). Arrows point to the enzyme bands
Fig. 4SDS-PAGE and active site labelling of purified pro-yrEnCL3 after auto-activation at various pH. The 38 kDa zymogen was autocatalytically processed to a 28 kDa form during incubation in 50 mM/100 mM CPB containing 2 mM DTT at 37 °C. After incubation at various pH values, the protein was run in 12% polyacrylamide gels and stained with Coomassie Brilliant Blue (pH 4, pH 5 and pH 6). Lane 1: 15 min incubation; Lane 2: 30 min; Lane 3: 60 min; Lane 4120 min. DCG-04, a 12% gel showing active site labelling of the processed enzyme with fluorescent affinity probe BODIPY green DCG-04. Lane 1: labelling by the affinity probe after 30 min incubation at pH 5; 1*, binding of the affinity probe was blocked by E-64 inhibitor. The 38 kDa zymogen and the 28 kDa processed enzyme are indicated by arrows
Fig. 5pH optima of rEnCLs and rEnCB activities, and the effect of inhibitors on enzyme activities. Activity assays were performed in 50 mM/100 mM CPB with 2 mM DTT at pH 3–8. Inhibition assays were run at the pH optima of the particular enzymes. The values are expressed as the percentage of maximum activity in the sample without inhibitor. 1, yrEnCL1; 2, yrEnCL3; 3, yrEnCB; 4, yrEnCB. a pH optima of endopeptidase (1–3) and exopeptidase (4) activities. b inhibition assays with FR substrate. c inhibition assays with LR substrate (1–2) and RR substrate (3). The inhibitors (10 μM) are indicated in the graphs above the columns: E-64, general irreversible inhibitor of clan CA cysteine peptidases; iCL, reversible peptide inhibitor of cathepsin L; CA-074, irreversible inhibitor of cathepsin B
Fig. 6SDS-PAGE of protein substrates degraded by recombinant EnCL1, EnCL3 and EnCB. Prior to electrophoresis in 12% polyacrylamide gel, the enzymes were incubated overnight with various protein substrates in 50 mM/100 mM CPB pH 4.5 containing 2 mM DTT. a Bovine serum albumin. b Bovine haemoglobin. c Human IgG. d Human type I collagen. e Human fibrinogen. Lane 1: controls (substrates without enzyme); Lane 2: yrEnCL1; Lane 3: yrEnCL3; 4: yrEnCB. Gels were stained with Coomassie Brilliant Blue
Fig. 7Reactions of anti-cathepsin antibodies with proteins on blots of E. nipponicum soluble extracts. Lane 1: mixed control (pre-immune sera); Lane 2: anti-brEnCL1 antibodies; Lane 3: anti-pro-yrEnCL3; Lane 4: anti-yrEnCB. Arrows point to the enzymes detected by specific antibodies
Fig. 8Immunolocalisation of EnCL1, EnCL3, and EnCB on histological sections of adult worms. Longitudinal sections of E. nipponicum adult; anterior part of the worm’s body is shown. EnCL1, reaction with anti-brEnCL1 antibodies; EnCL3, anti-pro-yrEnCL3 antibodies; EnCB, anti-yrEnCB antibodies. a Red fluorescence (Alexa Fluor 568 goat anti-mouse IgG) of the labelled secondary antibody in a dark field. b Merged picture of bright field view, red antibody fluorescence, and blue DAPI fluorescence. c Higher magnification of b. Reaction of antibodies raised against brEnCL1 and yrEnCL3 takes place in the lumen of the gut. Reaction of antibodies raised against yrEnCB takes place in the vesicular structures within vitelline cells. Control, pre-immune mouse sera in the order EnCL1 (a), EnCL3 (b), EnCB (c); merged picture of bright field view, red and blue fluorescence. No reaction with any of the control sera was detected
Fig. 9Localisation of mRNA encoding EnCL1 and EnCL3 using RNA in situ hybridisation. Longitudinal sections of E. nipponicum adult worms incubated with specific EnCL1/EnCL3 antisense-RNA probes. a Reaction in haematin cells of the digestive tract. b Higher magnification of the reacting areas from the same section. Controls were performed without any probe because the worms also produce anti-sense transcripts